BioMarin Discontinues Clinical Development of Drisapersen

BioMarin has announced that they were discontinuing the clinical development of drisapersen after interactions with both the FDA and EMA.
Source: Parent Project Muscular Dystrophy - Category: Neurology Source Type: news